Literature DB >> 3054278

[Loss of renal functional reserve following kidney transplantation and in patients with advanced disorders of liver function].

T Eisenhauer1, J Talartschik, H Hartmann, E Quentin, F Scheler.   

Abstract

Renal functional reserve capacity was evaluated in healthy controls, kidney transplant recipients and patients with impaired liver function by simultaneous measurements of periodic clearances of inulin, PAH and creatinine every 30 minutes before, during and after infusion of an amino acid (AA) solution. During AA infusion glomerular filtration rate rose in 10 healthy controls to about 35% above basal values (inulin clearance from 107 +/- 6 to 144 +/- 7 ml/min, p less than or equal to 0.0005), renal plasma flow increased by 27% (PAH clearance from 530 +/- 25 to 675 +/- 40 ml/min, p less than or equal to 0.002). 8 renal transplant recipients with good and stable renal function (creatinine clearance above 65 ml/min) showed no rise in GFR and RPF, as did 10 patients with severe impairment of liver function and normal basal kidney function (creatinine clearance above 100 ml/min). The lack of renal functional reserve in kidney transplant recipients might indicate a hyperfiltration of the transplanted kidney. This could affect the longtime prognosis of these patients. The liver seems to play a role in the mediation of the amino acid-induced rise of GFR, supporting the hypothesis of a putative liver hormone regulating GFR after protein ingestion or AA infusion.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3054278     DOI: 10.1007/bf01728959

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  33 in total

1.  Effect of glycine and glucagon on glomerular filtration and renal metabolic rates.

Authors:  J Johannesen; M Lie; F Kiil
Journal:  Am J Physiol       Date:  1977-07

2.  No rise in glomerular filtration rate after protein loading in cirrhotics.

Authors:  M Dratwa; A Burette; M Van Gossum; F Collart; R Wens; L Charlier; C Tielemans; M Deltenre
Journal:  Kidney Int Suppl       Date:  1987-10       Impact factor: 10.545

3.  Transplantation of cadaveric kidneys from patients with hepatorenal syndrome. Evidence for the functionalnature of renal failure in advanced liver disease.

Authors:  M H Koppel; J W Coburn; M M Mims; H Goldstein; J D Boyle; M E Rubini
Journal:  N Engl J Med       Date:  1969-06-19       Impact factor: 91.245

4.  Focal segmental glomerulosclerosis in kidney transplants.

Authors:  J S Cheigh; M Soliman; J Mouradian; L Tapia; R R Riggio; W Stubenbord; K H Stenzel; A L Rubin
Journal:  Transplant Proc       Date:  1981-03       Impact factor: 1.066

5.  Chronic glucocorticoid therapy amplifies glomerular injury in rats with renal ablation.

Authors:  D L Garcia; H G Rennke; B M Brenner; S Anderson
Journal:  J Clin Invest       Date:  1987-09       Impact factor: 14.808

6.  Response to acute protein load in kidney donors and in apparently normal postacute glomerulonephritis patients: evidence for glomerular hyperfiltration.

Authors:  B Rodríguez-Iturbe; J Herrera; R García
Journal:  Lancet       Date:  1985-08-31       Impact factor: 79.321

7.  Effect of glucagon and glomerulopressin on the renal function of the dog.

Authors:  J Uranga; R Fuenzalida; A L Rapoport; E del Castillo
Journal:  Horm Metab Res       Date:  1979-04       Impact factor: 2.936

8.  Hypertension after renal transplantation.

Authors:  C Bachy; G P Alexandre; C van Ypersele de Strihou
Journal:  Br Med J       Date:  1976-11-27

9.  The effect of short-term glucagon infusion on kidney function in normal man.

Authors:  H H Parving; J Noer; H Kehlet; C E Mogensen; P A Svendsen; L Heding
Journal:  Diabetologia       Date:  1977-08       Impact factor: 10.122

10.  Therapeutic implications of hypertension-induced glomerular injury. Comparison of enalapril and a combination of hydralazine, reserpine, and hydrochlorothiazide in an experimental model.

Authors:  L Raij; X C Chiou; R Owens; B Wrigley
Journal:  Am J Med       Date:  1985-09-27       Impact factor: 4.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.